Over my forty years or so in and around dealing rooms and financial markets, I have heard many theories as to how to approach that problem and have settled on a process that has worked for me.

IBM shares slump in worries about cost-cutting impact on consulting. Time to buy gold after the biggest drop in 4 years?

In a report released today, Gena Wang from Barclays maintained a Buy rating on Legend Biotech (LEGN – Research Report), with a price target of ...

The Basel Area in Switzerland is home to one of Europe’s brightest biotech ecosystems. Over the years, it has proven to be the favored location for many of the world’s biggest, best, and newest ...

Life Science & Biotech Meetup at Mainz University connects biotechnology initiatives of FORTHEM with the life science and biotechnology industry in Mainz and the local area In recent years ...

White House clarifies that the 125% tariffs are in addition to earlier 20% levies applied for fentanyl trafficking US stocks tumbled on Thursday as the White House clarified that the tariff rate on ...

Or, maybe, it's just a grey wolf with a few tweaks. American biotech company Colossal Biosciences made a surprise announcement Monday, claiming it had brought the dire wolf back from the dead ...

Axios has hired Katherine Davis as its biotechnology deals reporter. Davis has been at Crain’s Chicago Business covering health care and life sciences companies. She previously was a general ...

America must invest at least $15 billion over the next five years to support its domestic biotechnology sector if it doesn’t want to lose to China, warns a national security commission made up ...

However, the prospect of future industry-specific tariffs could intensify selling pressure on biotech stocks. Despite the uncertainty, top hedge fund managers have invested millions of dollars in ...

A biotech company says it has bred three animals with key physical features of the dire wolf — a species that has been extinct for more than 12,000 years. Colossal Biosciences says it used novel ...

Aimee Picchi is the associate managing editor for CBS MoneyWatch, where she covers business and personal finance. She previously worked at Bloomberg News and has written for national news outlets ...